MedicaidPrior AuthLow impact
Veopoz (pozelimab-bbfg) (Revised)
Humana·SC · Gastroenterology, Genetics, Pediatrics +1 more·Medicaid
Effective date
Jul 1, 2024
We identified it
Jun 24, 2026
Summary
Humana has established a new prior authorization policy for Veopoz (pozelimab-bbfg) injection for South Carolina Medicaid patients with CHAPLE disease. Prior authorization is required for patients 1 year and older with confirmed CD55 deficiency and genetic testing confirmation.
Action Required
Immediately: For South Carolina Medicaid patients receiving Veopoz (pozelimab-bbfg) for CHAPLE disease, billing team must obtain prior authorization before administration. Verify patient has confirmed CD55 loss of function mutation by genetic testing and is 1 year or older. Visit www.humana.com/PAL for preauthorization requirements. Claims will be denied without prior authorization.